Abstract
Individuals with inflammatory bowel disease (IBD) are at greater risk of developing colon cancer. Tumor-necrosis factor (TNF), elevated in IBD, can induce apoptosis in intestinal epithelial cells, therefore we hypothesized mice deficient in TNF receptors, TNFR1 or TNFR2, would be more susceptible to colitis-mediated colon cancer compared to wildtype (WT). Mice (WT, TNFR1−/− and TNFR2−/−) were treated with azoxymethane (AOM), followed by 4 cycles of dextran sulphate sodium (DSS 3% w/v 5 days + 14 days of water) to induce colitis. All mice experienced weight loss and loose stools after DSS. Disease severity did not differ significantly between strains. Control mice treated with DSS or AOM alone did not develop tumors. In WT mice, 6/9 developed tumors. Fewer TNFR1−/− mice (3/9) developed tumors compared to WT while all (7/7) TNFR2−/− mice developed tumors. TNFR1−/− mice had a fewer tumors than WT and TNFR2−/− mice, although tumor size did not differ between groups. Disease severity did not correlate with tumor number nor did inflammation scores differ between mice with or without dysplasia, indicating that the difference in the number of tumors was due to the genotype and not the degree of inflammation. Therefore, the absence of TNFR2, but not TNFR1, increases the susceptibility to tumor development in mice after inflammation. Funded by Dalhousie Cancer Research Program, Nova Scotia Health Research Foundation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.